In 2021, approval of cabotegravir (Apretude) as the first long-acting PrEP option provided patients an option to move from ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

A new injection to prevent HIV is expected to be approved by the US Food and Drug Administration later this month.

Attention deficit and hyperactivity disorder affects 5% to 7% of schoolgoing children, but doctors can only prescribe ...

The Trump administration's budget proposal for 2026 looks to make cuts to HIV prevention in clinics and community organizations.

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Lube, or personal lubricant, reduces friction during sex and masturbation. Learn the pros and cons of water-based, ...

As politicians, activists and researchers duke it out from labs and clinics and press conferences, those who have the most to ...

A Houston physician has sued the federal government to cut benefits through the Affordable Care Act that requires access to pre-exposure prophylaxis (PrEP). The case, Kennedy v. Braidwood, is now ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

A population-based study finds that nearly 15% of individuals using HIV preexposure prophylaxis are diagnosed with alcohol ...